| RS116807569 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy |
| RS1168076308 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS1168089009 |
DUOX2
|
Health Risk |
Likely pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS116809571 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1168101857 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS1168106708 |
DOK7
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome, Congenital myasthenic syndrome 10 |
| RS1168117828 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS116812032 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS1168129071 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1168132298 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1168144507 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS116814498 |
REPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1168146969 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS1168180592 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS1168183069 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS1168208619 |
LAMA5
|
Health Risk |
Pathogenic |
Nephrotic syndrome, IIa 26 |
| RS116823334 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1168254533 |
KPNA7
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 17, Oocyte/zygote/embryo maturation arrest 17 |
| RS116826217 |
LARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn mitochondrial myopathy, Inborn mitochondrial myopathy |
| RS1168273921 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1168286961 |
NPHP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Nephronophthisis 4 |
| RS1168314722 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Primary dilated cardiomyopathy |
| RS116833707 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO15A-related disorder, MYO15A-related disorder |
| RS1168346560 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS1168346867 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1168352165 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS116836001 |
MTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Disorders of Intracellular Cobalamin Metabolism, Methylcobalamin deficiency type cblG |
| RS1168363417 |
RORB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1168366157 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS116836855 |
AGRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 8, Inborn genetic diseases |
| RS1168371801 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1168374610 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS1168388514 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS1168396288 |
PCSK1
|
Health Risk |
Likely pathogenic |
Obesity due to prohormone convertase I deficiency, Obesity due to prohormone convertase I deficiency |
| RS1168397543 |
SERPING1
|
Health Risk |
Pathogenic |
— |
| RS1168400018 |
PCDH15
|
Health Risk |
Pathogenic |
Usher syndrome type 1F, Autosomal recessive nonsyndromic hearing loss 23 |
| RS1168401498 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS116840743 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Pallister-Hall syndrome |
| RS116840744 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Pallister-Hall syndrome |
| RS116840751 |
GLI3
|
Health Risk |
Pathogenic |
— |
| RS116840754 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Pallister-Hall syndrome |
| RS116840758 |
GLI3
|
Health Risk |
Likely pathogenic |
— |
| RS116840766 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS116840767 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Pallister-Hall syndrome |
| RS116840768 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Pallister-Hall syndrome |
| RS116840770 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS116840773 |
CAV3
|
Health Risk |
Likely pathogenic |
Rippling muscle disease 2, Rippling muscle disease 2 |
| RS116840776 |
CAV3
|
Health Risk |
Conflicting classifications of pathogenicity |
Rippling muscle disease 2, Limb-girdle muscular dystrophy |
| RS116840778 |
CAV3
|
Health Risk |
Conflicting classifications of pathogenicity |
Elevated circulating creatine kinase concentration, Rippling muscle disease 2 |
| RS116840782 |
CAV3
|
Health Risk |
Likely pathogenic |
Rippling muscle disease 2, Rippling muscle disease 2 |
| RS116840787 |
CAV3
|
Health Risk |
Pathogenic |
Long QT syndrome, Distal myopathy |
| RS116840789 |
CAV3
|
Health Risk |
Pathogenic/Likely pathogenic |
Rippling muscle disease 2, Elevated circulating creatine kinase concentration |
| RS116840795 |
CAV3
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiomyopathy |
| RS116840796 |
CAV3
|
Health Risk |
Likely pathogenic |
CAV3-related disorder, CAV3-related disorder |
| RS116840805 |
CAV3
|
Health Risk |
Pathogenic |
Rippling muscle disease 2, Long QT syndrome |
| RS116840806 |
RPS24
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 3, Diamond-Blackfan anemia 3 |
| RS116840807 |
RPL35A
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia 5, Diamond-Blackfan anemia 5 |
| RS116840808 |
RPL35A
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 5, Diamond-Blackfan anemia 5 |
| RS116840809 |
RPL35A
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 5, Diamond-Blackfan anemia 5 |
| RS116840811 |
RPS17
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 4, Diamond-Blackfan anemia |
| RS116840812 |
RPS17
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 4, Diamond-Blackfan anemia 4 |
| RS116840815 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth Neuropathy X |
| RS116840818 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease |
| RS116840819 |
GJB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth Neuropathy X |
| RS116840821 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth Neuropathy X |
| RS116840822 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease |
| RS116840823 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS116841148 |
LDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency, Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency |
| RS1168415754 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 14, Cardiovascular phenotype |
| RS1168427805 |
MMP2
|
Health Risk |
Pathogenic |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis nodulosis arthropathy spectrum |
| RS1168428802 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, KBG syndrome |
| RS116843064 |
ANGPTL4
|
Health Risk |
association |
Plasma triglyceride level quantitative trait locus, Plasma triglyceride level quantitative trait locus |
| RS1168431515 |
TRNT1
|
Health Risk |
Pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS1168449484 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS116845100 |
TCTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 24, Meckel syndrome |
| RS1168451622 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS116846245 |
AHCY
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, AHCY-related disorder |
| RS1168470052 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1168480900 |
CLRN1
|
Health Risk |
Pathogenic |
— |
| RS116848967 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, Inborn genetic diseases |
| RS1168492424 |
PEX13
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS1168493593 |
DNAI1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Kartagener syndrome |
| RS1168511209 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1168529666 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1168540279 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Hereditary sensory neuropathy-deafness-dementia syndrome |
| RS1168540941 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1168542133 |
CEP290
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 14, Joubert syndrome 5 |
| RS1168548075 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1168560365 |
F7
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital factor VII deficiency, Congenital factor VII deficiency |
| RS1168572368 |
CTRC
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1168592296 |
CHRNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome |
| RS1168594259 |
APOB
|
Health Risk |
Likely pathogenic |
Familial hypobetalipoproteinemia 1, Familial hypobetalipoproteinemia 1 |
| RS1168625480 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1168641193 |
POLR3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neonatal pseudo-hydrocephalic progeroid syndrome, Leukodystrophy |
| RS1168653552 |
SCARB2
|
Health Risk |
Likely pathogenic |
Action myoclonus-renal failure syndrome, Action myoclonus-renal failure syndrome |
| RS1168668932 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1168669263 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1168679768 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS1168687230 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS1168688853 |
ASNS
|
Health Risk |
Pathogenic |
— |